title: Reply to "Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?".
authors.affiliation: Retired Physician, Sergy Haut, France dfedson@wanadoo.fr.
authors.forename: David S
authors.initials: DS
authors.lastname: Fedson
authors.affiliation: University of Illinois College of Medicine, Chicago, Illinois, USA.
authors.forename: Jeffrey R
authors.initials: JR
authors.lastname: Jacobson
authors.affiliation: Practicing Physician, Trondheim, Norway.
authors.forename: Ole Martin
authors.initials: OM
authors.lastname: Rordam
authors.affiliation: Alpert Medical School of Brown University, Providence, Rhode Island, USA.
authors.forename: Steven M
authors.initials: SM
authors.lastname: Opal
mesh_terms: D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use*; D042783:Endothelial Cells / Q000187:drug effects* / Q000502:physiology*; D019142:Hemorrhagic Fever, Ebola / Q000188:drug therapy*; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000627:therapeutic use*
chemical_list: D057911:Angiotensin Receptor Antagonists; D006903:Hydroxymethylglutaryl CoA Reductases